Potential therapeutic uses of N-methyl-D-aspartate antagonists in cerebral ischemia.
Albers
G W
GW
Department of Neurology and Neurological Sciences, Stanford University Medical Center, CA 94305.
D001224:Aspartic Acid / Q000031:analogs & derivatives* / Q000037:antagonists & inhibitors; D002545:Brain Ischemia / Q000188:drug therapy* / Q000503:physiopathology; D005971:Glutamates; D018698:Glutamic Acid; D006801:Humans; D008954:Models, Biological; D016202:N-Methylaspartate; D009420:Nervous System / Q000187:drug effects; D017470:Receptors, Glutamate; D016194:Receptors, N-Methyl-D-Aspartate; D017981:Receptors, Neurotransmitter
D005971:Glutamates; D017470:Receptors, Glutamate; D016194:Receptors, N-Methyl-D-Aspartate; D017981:Receptors, Neurotransmitter; D001224:Aspartic Acid; D018698:Glutamic Acid; D016202:N-Methylaspartate